Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Wonnacott

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Pharmacology|February 28, 2002
Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cellsDiana L Ridley, Jukka Pakkanen, Susan Wonnacott
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 23, 2012
Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypesAlexandra Kennett, David J Heal, Susan Wonnacott
British Journal of Pharmacology|June 7, 2005
Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cellsJacques Barik, Federico Dajas-Bailador, Susan Wonnacott
European Journal of Biochemistry|June 9, 2004
Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypesAnnette Nicke, Susan Wonnacott, Richard J Lewis
British Journal of Pharmacology|May 25, 2026
Emerging therapeutic opportunities for psychedelic and related drugsSusan Wonnacott, Gary J Stephens, Trevor Sharp
Current Opinion in Pharmacology|January 22, 2005
Nicotine: from molecular mechanisms to behaviourSusan Wonnacott, Nimish Sidhpura, David J K Balfour
Neuropharmacology|April 15, 2010
Oligomerisation differentially affects the acute and chronic actions of amyloid-beta in vitroNeal Innocent, Nicholas Evans, Christopher Hille, et al.
Molecular Pharmacology|October 24, 2003
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter releaseFederico A Dajas-Bailador, Kaisa Heimala, Susan Wonnacott
Journal of Molecular Neuroscience : MN|December 29, 2006
Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmittersSusan Wonnacott, Jacques Barik, Jane Dickinson, et al.
Neuroscience Letters|January 20, 2010
Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span taskSamantha L Rushforth, Claire Allison, Susan Wonnacott, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|February 28, 2002
Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cellsDiana L Ridley, Jukka Pakkanen, Susan Wonnacott
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 23, 2012
Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypesAlexandra Kennett, David J Heal, Susan Wonnacott
British Journal of Pharmacology|June 7, 2005
Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cellsJacques Barik, Federico Dajas-Bailador, Susan Wonnacott
European Journal of Biochemistry|June 9, 2004
Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypesAnnette Nicke, Susan Wonnacott, Richard J Lewis
British Journal of Pharmacology|May 25, 2026
Emerging therapeutic opportunities for psychedelic and related drugsSusan Wonnacott, Gary J Stephens, Trevor Sharp
Current Opinion in Pharmacology|January 22, 2005
Nicotine: from molecular mechanisms to behaviourSusan Wonnacott, Nimish Sidhpura, David J K Balfour
Neuropharmacology|April 15, 2010
Oligomerisation differentially affects the acute and chronic actions of amyloid-beta in vitroNeal Innocent, Nicholas Evans, Christopher Hille, et al.
Molecular Pharmacology|October 24, 2003
The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter releaseFederico A Dajas-Bailador, Kaisa Heimala, Susan Wonnacott
Journal of Molecular Neuroscience : MN|December 29, 2006
Nicotinic receptors modulate transmitter cross talk in the CNS: nicotinic modulation of transmittersSusan Wonnacott, Jacques Barik, Jane Dickinson, et al.
Neuroscience Letters|January 20, 2010
Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: a novel use of the odour span taskSamantha L Rushforth, Claire Allison, Susan Wonnacott, et al.
Pageof 7